About

Felix Merboth is a leading surgical researcher whose work centers on advancing the treatment of esophageal cancer through robotic-assisted minimally invasive esophagectomy (RAMIE). His primary contributions lie in demonstrating the clinical superiority of robotic techniques over traditional open surgery. In a landmark prospective multicenter study from the German da Vinci Xi registry (2022, 20 citations), Merboth helped establish RAMIE as a standardized, safe approach for esophageal tumors. His propensity score-matched analysis (2022, 15 citations) further revealed a critical, patient-centered benefit: robotic esophagectomy significantly reduces postoperative sarcopenia—the loss of muscle mass—within the first year, improving recovery and quality of life. Additionally, his single-center strategy change study (2021, 15 citations) provided compelling evidence that transitioning from open to robotic surgery lowers morbidity. By systematically validating RAMIE’s advantages through rigorous comparative research, Merboth has shaped modern surgical protocols, offering patients less invasive options with better long-term outcomes. His work, published in both English and German journals, underscores his role as a key figure in the global shift toward precision, robot-assisted oncologic surgery.

Research Focus

Key Achievements

3
H-Index
4
Papers
53
Total Citations
13
Avg Citations/Paper
🏆 Most Cited Paper
Robotic-assisted minimally invasive Ivor Lewis esophagectomy within the prospective multicenter German da Vinci Xi registry trial
20 citations · 2022
📈 Most Prolific Year: 2022 (2 Papers)
🤝 Key Collaborators: 25
🏛 Institutions: University Hospital Carl Gustav Carus, Klinik und Poliklinik für Psychotherapie und Psychosomatik, German Cancer Research Center, DKFZ-ZMBH Alliance

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago